Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
Biotech firm Gene Solutions has presented successful real-world data for its AI-powered SPOT-MAS 10 cancer screening test at the ASCO Breakthrough 2026 conference. The study, involving over 84,000 individuals across Asia, demonstrates the test's effectiveness in detecting cancers that often lack routine screening programs.
A blood-based cancer screening technology developed in Asia is gaining international attention after real-world data from more than 84,145 individuals were presented at ASCO Breakthrough 2026 and highlighted by the American Society of Clinical Oncology. For Gene Solutions, this milestone underscores the growing global relevance of Asia-led multi-cancer detection innovation.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in